Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04099823 · ClinicalTrials.gov registry record · NA

MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics

A NA study of Alzheimer Disease and Hydrocephalus, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04099823 is a NA study of Alzheimer Disease and Hydrocephalus that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04099823, a NA study of Alzheimer Disease and Hydrocephalus, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.

Interventions

  • OTHER MRI screening form
  • DIAGNOSTIC_TEST Urine pregnancy test
  • DIAGNOSTIC_TEST MR brain

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-10-31
Est. Completion 2027-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04099823

The ClinicalTrials.gov registry entry for NCT04099823 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which MRI screening form is the first listed.

NCT04099823 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04099823 about?

NCT04099823 is a clinical study titled "MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics". The Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.

What is the current status of trial NCT04099823?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-10-31. Estimated completion is 2027-01.

What conditions does trial NCT04099823 study?

This clinical trial studies the following conditions: Alzheimer Disease, Hydrocephalus.

What interventions are being tested in trial NCT04099823?

The interventions under investigation include: MRI screening form (OTHER), Urine pregnancy test (DIAGNOSTIC_TEST), MR brain (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04099823?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04099823 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.